{"product_id":"npc-tb10","title":"TB10","description":"\u003cdetails open style=\"margin-top:30px; background:#05070A; border:1px solid #12343b; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:28px; cursor:pointer; color:#ffffff; font-size:26px; font-weight:900; letter-spacing:1px;\"\u003e\n    TB-500 Research Protocol\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:32px; background:#0b1115; color:#c7d4d8; line-height:1.8;\"\u003e\n\n    \u003cp style=\"color:#7ed8e6; text-transform:uppercase; letter-spacing:3px; font-size:13px; margin:0 0 12px;\"\u003e\n      Northern Peptide Collective\n    \u003c\/p\u003e\n\n    \u003ch2 style=\"color:#ffffff; font-size:40px; margin:0 0 20px; line-height:1.1;\"\u003e\n      TB-500\n    \u003c\/h2\u003e\n\n    \u003cp style=\"font-size:16px; color:#c7d4d8; line-height:1.9; margin-bottom:30px;\"\u003e\n      Research-focused information sheet covering TB-500, tissue repair pathway discussions,\n      recovery research, dosage references, reconstitution guidance, stack information,\n      FAQ, and laboratory documentation.\n    \u003c\/p\u003e\n\n    \u003cdiv style=\"display:grid; grid-template-columns:repeat(auto-fit,minmax(220px,1fr)); gap:18px; margin-bottom:35px;\"\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eResearch Category\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003eRecovery \/ Tissue Research\u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eCommon Range\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003e500mcg–1000mcg daily discussions\u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eFrequency\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003eOnce daily protocol discussions\u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eCycle Window\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003e8–12 week discussions\u003c\/p\u003e\n      \u003c\/div\u003e\n\n    \u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Compound Breakdown\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; line-height:1.9; color:#334;\"\u003e\n\n    \u003ch3\u003eTB-500\u003c\/h3\u003e\n\n    \u003cp\u003e\n      TB-500 is commonly discussed as a synthetic fragment associated with thymosin beta-4 research.\n      It is frequently referenced in tissue repair, recovery, mobility, inflammation-response,\n      wound healing, and cell migration research discussions.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      Research communities often discuss TB-500 in relation to actin regulation,\n      angiogenesis pathways, tissue remodeling, repair signaling, and recovery-focused\n      laboratory models.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Wellness Focus\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px;\"\u003e\n\n    \u003cul style=\"line-height:2; color:#334;\"\u003e\n      \u003cli\u003eTissue repair research\u003c\/li\u003e\n      \u003cli\u003eRecovery pathway discussions\u003c\/li\u003e\n      \u003cli\u003eMobility and flexibility research\u003c\/li\u003e\n      \u003cli\u003eInflammation-response pathway discussions\u003c\/li\u003e\n      \u003cli\u003eSoft tissue support research\u003c\/li\u003e\n      \u003cli\u003eCell migration and repair signaling\u003c\/li\u003e\n      \u003cli\u003eAthletic recovery research models\u003c\/li\u003e\n      \u003cli\u003eWound-healing pathway discussions\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#05070A; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900; color:#ffffff;\"\u003e\n    Suggested Research Dosing Information\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#c7d4d8;\"\u003e\n\n    \u003ctable style=\"width:100%; border-collapse:collapse; margin-top:10px;\"\u003e\n\n      \u003ctr\u003e\n        \u003cth style=\"border:1px solid #12343b; padding:14px; text-align:left; color:#ffffff;\"\u003eProtocol Phase\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #12343b; padding:14px; text-align:left; color:#ffffff;\"\u003eDaily Research Range\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #12343b; padding:14px; text-align:left; color:#ffffff;\"\u003eNotes\u003c\/th\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eWeeks 1–2\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003e500mcg daily\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eIntroductory research reference\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eWeeks 3–4\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003e600mcg–750mcg daily\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eGradual titration discussion\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eWeeks 5–8\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003e750mcg–1000mcg daily\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eTarget protocol discussion\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eWeeks 9–12\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003e750mcg–1000mcg daily\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eExtended recovery research window\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eOptional Extension\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eProtocol dependent\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eSome discussions extend to 16 weeks\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n    \u003c\/table\u003e\n\n    \u003cp style=\"font-size:13px; color:#9daeb4; margin-top:18px; line-height:1.8;\"\u003e\n      PeptideDosages references a 10mg TB-500 protocol starting at 500mcg daily,\n      increasing by roughly 100–150mcg every two weeks, targeting 750–1000mcg daily\n      by weeks 5–12, with once-daily subcutaneous research discussions and an 8–12 week\n      cycle window. This information is educational only and not medical guidance.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Vial Size Reference\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ctable style=\"width:100%; border-collapse:collapse;\"\u003e\n\n      \u003ctr\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eVial Size\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eCommon Discussion\u003c\/th\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e5mg vial\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eLower-volume recovery research reference\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e10mg vial\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eCommon protocol reference for extended daily structures\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eBlend formats\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eFrequently discussed with BPC-157 recovery stacks\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n    \u003c\/table\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Reconstitution Reference\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ctable style=\"width:100%; border-collapse:collapse;\"\u003e\n\n      \u003ctr\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eBAC Water\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eApproximate Concentration Reference\u003c\/th\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e1mL\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eHigher concentration preparation\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e2mL\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eBalanced concentration preparation\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e3mL\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eLower concentration \/ easier measurement reference\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n    \u003c\/table\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Example Concentration Reference\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ctable style=\"width:100%; border-collapse:collapse;\"\u003e\n\n      \u003ctr\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eExample\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eReference Calculation\u003c\/th\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e10mg vial + 1mL BAC\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e10mg\/mL reference concentration\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e10mg vial + 2mL BAC\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e5mg\/mL reference concentration\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e10mg vial + 3mL BAC\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e3.33mg\/mL reference concentration\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n    \u003c\/table\u003e\n\n    \u003cp style=\"font-size:13px; color:#667; line-height:1.8; margin-top:18px;\"\u003e\n      Concentration references are included for laboratory calculation education only.\n      Always calculate based on actual vial amount, reconstitution volume, and target research amount.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Stack Information\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ch3\u003eBPC-157\u003c\/h3\u003e\n    \u003cp\u003eFrequently discussed with TB-500 in recovery, repair, and soft-tissue research stacks.\u003c\/p\u003e\n\n    \u003ch3\u003eGHK-Cu\u003c\/h3\u003e\n    \u003cp\u003eCommonly referenced in skin, tissue remodeling, and regenerative research discussions.\u003c\/p\u003e\n\n    \u003ch3\u003eKPV\u003c\/h3\u003e\n    \u003cp\u003eOften included in inflammatory response and recovery pathway discussions.\u003c\/p\u003e\n\n    \u003ch3\u003eGLOW \/ Recovery Blends\u003c\/h3\u003e\n    \u003cp\u003eTB-500 is frequently referenced in multi-compound recovery and repair blend discussions.\u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Usage Pattern Discussions\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003cul\u003e\n      \u003cli\u003eOnce-daily recovery research structures\u003c\/li\u003e\n      \u003cli\u003eGradual titration discussions\u003c\/li\u003e\n      \u003cli\u003e8–12 week recovery windows\u003c\/li\u003e\n      \u003cli\u003eOptional extension discussions up to 16 weeks\u003c\/li\u003e\n      \u003cli\u003eSystematic site-rotation discussions in injection research models\u003c\/li\u003e\n      \u003cli\u003eRepair-focused stack discussions with BPC-157\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Storage Information\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ch3\u003eLyophilized \/ Unmixed\u003c\/h3\u003e\n\n    \u003cul\u003e\n      \u003cli\u003eStore frozen at approximately −20°C \/ −4°F.\u003c\/li\u003e\n      \u003cli\u003eProtect from direct light and moisture.\u003c\/li\u003e\n      \u003cli\u003eKeep sealed until laboratory preparation.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n    \u003ch3\u003eAfter Reconstitution\u003c\/h3\u003e\n\n    \u003cul\u003e\n      \u003cli\u003eRefrigerate at 2–8°C \/ 35–46°F.\u003c\/li\u003e\n      \u003cli\u003eAvoid repeated freeze-thaw cycles.\u003c\/li\u003e\n      \u003cli\u003eStore away from direct sunlight.\u003c\/li\u003e\n      \u003cli\u003eUse sterile handling practices.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Educational Visuals \u0026amp; Research Notes\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003cp\u003e\n      TB-500 is frequently referenced in recovery-focused research involving tissue repair,\n      cellular migration, angiogenesis pathways, inflammation-response discussions, and\n      soft-tissue remodeling.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      Research communities commonly discuss TB-500 in relation to performance recovery,\n      mobility support, repair signaling, wound-healing models, and advanced peptide stacks\n      with BPC-157.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Frequently Asked Questions\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat is TB-500 commonly researched for?\u003c\/strong\u003e\u003cbr\u003e\n      Recovery pathways, tissue repair discussions, mobility support, wound-healing models,\n      and repair signaling research.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat peptide is TB-500 related to?\u003c\/strong\u003e\u003cbr\u003e\n      TB-500 is commonly discussed as a synthetic fragment associated with thymosin beta-4 research.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat dosing structures are commonly discussed?\u003c\/strong\u003e\u003cbr\u003e\n      Public research discussions commonly reference once-daily structures starting around 500mcg\n      and gradually titrating toward 750–1000mcg daily.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat cycle length is commonly discussed?\u003c\/strong\u003e\u003cbr\u003e\n      8–12 week recovery research windows are commonly referenced, with some discussions extending to 16 weeks.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat compounds are commonly stacked with TB-500?\u003c\/strong\u003e\u003cbr\u003e\n      BPC-157, GHK-Cu, KPV, and recovery-focused research blends are commonly discussed.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eIs TB-500 intended for human consumption?\u003c\/strong\u003e\u003cbr\u003e\n      No. TB-500 is intended strictly for laboratory and educational research reference purposes only.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdiv style=\"margin-top:24px; background:#05070A; padding:34px; border-radius:18px; text-align:center; font-family:Arial,sans-serif;\"\u003e\n\n  \u003ch2 style=\"color:#ffffff; margin-top:0;\"\u003e\n    COA \u0026amp; Documentation\n  \u003c\/h2\u003e\n\n  \u003cp style=\"color:#c7d4d8; line-height:1.8;\"\u003e\n    View batch documentation, laboratory information, and product verification.\n  \u003c\/p\u003e\n\n  \u003ca href=\"PASTE_COA_LINK_HERE\" target=\"_blank\" style=\"\n      background:#00d9ff;\n      color:#05070A;\n      padding:16px 34px;\n      border-radius:10px;\n      text-decoration:none;\n      font-weight:bold;\n      display:inline-block;\n      letter-spacing:1px;\n     \"\u003e\n    VIEW COA DOCUMENT\n  \u003c\/a\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv style=\"margin-top:24px; background:#fff3cd; border:1px solid #ffe08a; padding:22px; border-radius:14px; font-size:13px; line-height:1.8; font-family:Arial,sans-serif;\"\u003e\n\n  \u003cstrong\u003eImportant Notice:\u003c\/strong\u003e\n\n  This information is intended strictly for laboratory and educational research reference purposes only.\n  Not approved for human consumption, medical use, diagnosis, treatment, or prevention of disease.\n\n\u003c\/div\u003e","brand":"Northern Peptide Collective","offers":[{"title":"TB10-SINGLE \/ 10 mg x 10vials","offer_id":47956716585134,"sku":"TB10-SINGLE","price":60.0,"currency_code":"CAD","in_stock":true},{"title":"TB10-10PACK \/ 10 mg x 10vials","offer_id":47956716617902,"sku":"TB10-10PACK","price":360.0,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0750\/4707\/6014\/files\/dbd88a68-3338-4d6c-a5f2-998939951459.png?v=1780849318","url":"https:\/\/northernpeptidecollective.ca\/products\/npc-tb10","provider":"Northern Peptide Collective","version":"1.0","type":"link"}